Descemet Membrane Endothelial Keratoplasty versus Descemet Stripping Automated Endothelial Keratoplasty in Complicated Vitrectomized Eyes.


Journal

Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 5 3 2021
medline: 1 3 2022
entrez: 4 3 2021
Statut: ppublish

Résumé

Vitrectomized eyes pose a technical challenge when performing endothelial keratoplasty (EK). The aim of the study was to compare outcomes of Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK) in complex eyes undergoing pars plana vitrectomy (PPV) prior to or during surgery. This retrospective study included consecutive eyes that underwent pars plana infusion-assisted DMEK or pull-through DSAEK which underwent PPV prior to or during the EK at a tertiary center. Included were eyes with at least 1-year follow-up. The main outcome measures were best-corrected visual acuity (BCVA) and serious adverse events. Fifty-two eyes (n = 52) with a mean follow-up time of 24.6 ± 7.4 months were included. Both groups were similar in terms of baseline characteristics although the DMEK group had a significantly larger proportion of Fuchs' patients ( A significant and similar improvement in BCVA was achieved following DMEK and DSAEK in complex vitrectomized eyes. Patients should be advised regarding the higher rates of potential serious complications associated with a pars plana infusion DMEK in this situation.

Identifiants

pubmed: 33657945
doi: 10.1080/02713683.2021.1892150
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1283-1290

Auteurs

Michael Mimouni (M)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Nir Sorkin (N)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.
Department of Ophthalmology, Tel Aviv Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Jacqueline Slomovic (J)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Eli Kisilevsky (E)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Zale Mednick (Z)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Eyal Cohen (E)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Tanya Trinh (T)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Gisella Santaella (G)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Clara C Chan (CC)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

David S Rootman (DS)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Allan R Slomovic (AR)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH